Morning Overview on MSN
The FDA cleared a three-drug maintenance combination for HER2-positive breast cancer built around tucatinib
Tucatinib, trastuzumab and pertuzumab became an approved maintenance regimen on Oct. 7, 2026, when the Food and Drug ...
Sophomore Dame Sarr and freshman Joaquim Boumtje Boumtje were the offensive leaders for the Blue Devils, each scoring 19 ...
Akeso, Inc. (9926.HK) ('Akeso' or the 'Company') announced that the first patient has been dosed in a Phase III clinical ...
A man believed to be the source of the illicit substance that killed a Woman in the Township of Caledonia, has been charged ...
A new case report in the Annals of Hematology describes a woman whose rare primary thyroid diffuse large B-cell lymphoma ...
Experts said the lawsuits represent an unprecedented attempt to use public nuisance law, traditionally applied in ...
Is the Treatment Paradigm Changing? / ASCO, Breast Cancer, cancer, cancer care, cancer treatment, chemotherapy, ...
NEW YORK – New York Attorney General Letitia James today joined a bipartisan coalition of 47 other attorneys general in securing $1 million from Ascend ...
Pfizer bagged a coveted first-line maintenance approval for Tukysa. In combination with HER2 antibody drugs, the treatment ...
WHO’s first global childhood obesity guidelines put diet, physical activity and behavioural support first, limiting ...
United States President Donald Trump has been traveling all across the country over the past several weeks, speaking at rallies and political events ahead of next month’s midterm elections. On ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results